Sreoshi Chatterjee 452 posts 0 comments

electroCore sought 510(k) clearance from the U.S Food and Drug Administration for an extended label for gammaCore (nVNS) as an acute treatment of pain associated with migraine in adult…
Read More...

Dragonfly Therapeutics welcomes on board Dr. Jean-Marie Cuillerot, MD as its Chief Medical Officer. Dr. Cuillerot set to spearhead clinical development of Dragonfly's natural Killer…
Read More...

Harris Healthcare asserts that Emerald Health Information Systems will transition from MediSolution, Harris Healthcare's sister company under the Harris umbrella, to Harris Healthcare…
Read More...

Supplier of quality compounding products, supplies and equipment, Letco Medical along with ARL Bio Pharma collaborate to roll out their joint Quality Savings Program. The program…
Read More...

Global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease, QT Vascular successfully…
Read More...

Wuxi Biologics and Aravive Biologics collaborate to extend their biologics manufacturing collaboration, based on the rapid success achieved in the process development, scale-up and cGMP…
Read More...

Clinical development Type C meeting with the US Food and Drug Administration (FDA) for its orally active anti-fibrotic lead drug candidate, PBI-4050 was declared by Prometic Life…
Read More...

Clinical-stage, biotherapeutics company focused on the development of oncolytic immunotherapy products for cancer, SillaJen declared the commencement of Phase 1/2 clinical trial of…
Read More...

In a bid to bring on board fresh participants for its weight loss surgery surgery thus making it accessible patients with  a considerably low BMI of 30-35, New Jersey Bariatric Center…
Read More...

Aradigm Corporation asserted that it received a Complete Response Letter from the US Food and Drug Administration regarding its New Drug Application (NDA) for Linhaliq for treating …
Read More...